Provided by Tiger Trade Technology Pte. Ltd.

REMEGEN

70.250
-1.650-2.29%
Volume:2.45M
Turnover:175.39M
Market Cap:39.59B
PE:46.53
High:74.800
Open:73.600
Low:70.100
Close:71.900
52wk High:124.000
52wk Low:63.300
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:2.21
T/O Rate:1.17%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.510
ROE:109.10%
ROA:39.01%
PB:4.07
PE(LYR):46.53
PS:4.22

Loading ...

RemeGen Repurchases 60,000 Shares Through September

Stock News
·
4 hours ago

RemeGen Maintains Stable Share Base in September; Executes RMB2.16 Million A-Share Buyback for Incentive Scheme

Bulletin Express
·
Oct 06

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02

Hong Kong Stock Movers: Innovative Drug Stocks Retreat, InnoCare Pharma (09969) Falls Over 8%, RemeGen (09995) Drops Nearly 6%

Stock News
·
Oct 02

Movement Alert|REMEGEN Falls 7.65% in Regular Trading, Trading at 71.45 HKD

Market Focus
·
Oct 02

Does Long Term Trial Data Change The Bull Case For RemeGen Stock (SEHK:9995)?

Simply Wall St.
·
Oct 01

RemeGen Biotech Shares Rise Over 3% in Late Trading; Telitacicept gMG China Phase III Analysis Results Presented at AANEM Annual Meeting

Stock News
·
Sep 30

Movement Alert|REMEGEN Rises 5.13% in Regular Trading, Biotech Sector Rally Extends Amid Innovative Drug Boom

Market Focus
·
Sep 29

Movement Alert|REMEGEN Falls 5.08% in Regular Trading, Biotech Sector Under Pressure Amid Earnings Sustainability Concerns

Market Focus
·
Sep 24

RemeGen Turns Profitable on Licensing Windfall and Strong Drug Sales; H1 Revenue Jumps to RMB 5.85 Billion

Bulletin Express
·
Sep 23

HK Movers | Innovative Drug Stocks Rally Broadly; LEPU BIO, INNOCARE, AKESO Jump Over 7%

Tiger Newspress
·
Sep 21

Movement Alert|REMEGEN Rises 5.35% in Regular Trading, RC148 Lung Cancer Clinical Data Debut at World Lung Cancer Conference Draws Market Attention

Market Focus
·
Sep 21

RemeGen's RC148 Challenges Akeso's Dominance in Lung Cancer Space, Projected to Hit 3.6B Yuan in Peak Sales

Deep News
·
Sep 17

HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty

Stock News
·
Sep 11

Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference

Deep News
·
Sep 07

RemeGen Maintains Stable Share Base; Minor A-Share Buyback Adds to Treasury in August 2026

Bulletin Express
·
Sep 04

REMEGEN Discloses Cumulative Buyback of 41,000 A-Shares by End of August

Stock News
·
Sep 02

Executive Director Wang Yuxiao Reduces Stake in Remegen (09995) by 13,500 Shares at Approximately HK$81.54 Each

Stock News
·
Sep 02

Executive Director Wang Yuxiao Reduces Stake in Remegen with Share Sale

Stock News
·
Sep 01

RemeGen (SEHK:9995) Stock Profit Surge Meets Doubts Over Earnings Durability

Simply Wall St.
·
Aug 26